Concepedia

Haiyuan Zhu

HZ

Statistics

Publications

13

Citations

944

H-Index

12

Active since

2002

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Allergan (United States)

Indiana University School of Medicine

University of Liverpool

Indiana University – Purdue University Indianapolis

Haiyuan Zhu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Publications per year

2002–2024

13

Publications

13

Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial

Inder Kaul, Sharon Sawchak, Christoph U. Correll et al. · The Lancet · 2023 · 223 citations

Medicine, Pharmacology, Psychiatry +16

Efficacy and Safety of Intranasal Peptide YY3–36 for Weight Reduction in Obese Adults

Ira Gantz, Ngozi Erondu, Madhuja Mallick et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 162 citations · Full text

Agriculture, Nutritional Sciences, Pharmacology +17

Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia

Inder Kaul, Sharon Sawchak, David P. Walling et al. · JAMA Psychiatry · 2024 · 161 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Sample size calculation for comparing two negative binomial rates

Haiyuan Zhu, Hassan Lakkis · Statistics in Medicine · 2013 · 111 citations

Public Health, Biostatistics, Clinical Epidemiology +14

Cardiovascular Safety in Patients Receiving Roflumilast for the Treatment of COPD

William B. White, Glen E. Cooke, Peter R. Kowey et al. · CHEST Journal · 2013 · 99 citations

Pharmacy, Cardiology, Pharmacotherapy +8

1–5 of 13